insights_auto
Why is SABS down 3.90%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
$2.96
arrow_downward
-3.90%(-0.12) 1D
Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
$3.08
High
$3.15
Low
$2.85
Mkt. cap
266.66M
Avg. vol.
700.24K
Volume
658.12K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
Open
$3.08
High
$3.15
Low
$2.85
Mkt. cap
266.66M
Avg. vol.
700.24K
Volume
658.12K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
News stories
From web sources and news partners
BigGo Finance
·
1 hour ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
TradingKey
·
12 hours ago
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
The Motley Fool
·
22 hours ago
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
StoneX
·
2 days ago
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Florida, United States
SectorHealth Care
IndustryBiotechnology
Websitesab.bio